HAPPEportfolio

HAPPE Spine MTI news

HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort

We’re proud to share that HAPPE Spine, a portfolio company of cultivate(MD), has been selected for the MedTech Innovator 2025 Accelerator Cohort, an honor reserved for the top 4% of nearly 1,500 global applicants. This recognition reflects both the strength of HAPPE’s mission and the game-changing potential of their breakthrough spinal implant technology. MedTech Innovator […]

HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort Read More »

HAPPE Spine and cultivate(MD)

HAPPE Spine Announces First Clinical Use of the INTEGRATE®-C Interbody Fusion System

Grand Rapids, Mich., August 14, 2023—HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at the Beacon Health System – Memorial Hospital in South Bend, Indiana. Dr. Smith said, “The Integrate-C handled extremely well and went right to work. The

HAPPE Spine Announces First Clinical Use of the INTEGRATE®-C Interbody Fusion System Read More »

Interview with Andy Iott of HAPPE Spine

Interview with Andrew Iott, the New President and CEO of HAPPE Spine

We recently had the opportunity to meet with Andrew Iott, HAPPE Spine’s new President and CEO. HAPPE Spine announced in December of 2022 that Andrew Iott accepted an offer to become the President and CEO. Mr. Iott brings over twenty years of experience in medical device product development and commercialization, with extensive knowledge of the

Interview with Andrew Iott, the New President and CEO of HAPPE Spine Read More »